Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Singapore eDevelopment Limited
Singapore eDevelopment Limited
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Ingredients
Impact Biomedical initiates research programme to solve the patent cliff
The primary cause of the patent crisis is that most techniques for modifying natural molecules to pharmaceutical grade products are essentially 'played out'
Research & Development
Equivir shows prophylactic COVID-19 results in independent testing
Impact Biomedical has announced in vitro success with Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing
Ingredients
Impact BioMedical looks at compounds that block coronavirus mechanisms
The coronavirus has presented a unique challenge to exploit a 'hand shake' docking site to human cellular membranes that is atypical of Influenza and Rhinovirus
Research & Development
Singapore eDevelopment researches universal drug platform
Six month target for validating lab data, twelve month target for completion of platform
Subscribe now